{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:40:20Z","timestamp":1789566020665,"version":"build-2803163510"},"reference-count":26,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1248\/bpb.b16-00041","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T18:12:23Z","timestamp":1472667143000},"page":"1549-1554","source":"Crossref","is-referenced-by-count":14,"title":["A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate"],"prefix":"10.1248","volume":"39","author":[{"given":"Takefumi","family":"Oizumi","sequence":"first","affiliation":[{"name":"Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University"},{"name":"Department of Oral and Maxillofacial Surgery, Japan Community Health Care Organization Sendai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Dentistry and Oral Surgery, National Hospital Organization Tokyo Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Japan Community Health Care Organization Sendai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Dentistry and Oral Surgery, National Hospital Organization Tokyo Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Otsuru","sequence":"additional","affiliation":[{"name":"Department of Dentistry and Oral Surgery, National Hospital Organization Tokyo Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Tohoku Fukushi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Graduate School of Medicine, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Itoi","sequence":"additional","affiliation":[{"name":"Division of Orthopaedic Surgery, Graduate School of Medicine, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Division of Molecular Regulation, Graduate School of Dentistry, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University"},{"name":"Division of Molecular Regulation, Graduate School of Dentistry, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Fliefel R, Tr\u00f6ltzsch M, K\u00fchnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. <i>Int. J. Oral Maxillofac. Surg.<\/i>, <b>44<\/b>, 568\u2013585 (2015).","DOI":"10.1016\/j.ijom.2015.01.026"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Pazianas M. Osteonecrosis of the jaw and the role of macrophages. <i>J. Natl. Cancer Inst.<\/i>, <b>103<\/b>, 232\u2013240 (2011).","DOI":"10.1093\/jnci\/djq516"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Urade M, Tanaka N, Furusawa K, Shimada J, Shibata T, Kirita T, Yamamoto T, Ikebe T, Kitagawa Y, Fukuta J. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan. <i>J. Oral Maxillofac. Surg.<\/i>, <b>69<\/b>, e364\u2013e371 (2011).","DOI":"10.1016\/j.joms.2011.03.051"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) AAOMS. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. <i>J. Oral Maxillofac. Surg.<\/i>, <b>65<\/b>, 369\u2013376 (2007).","DOI":"10.1016\/j.joms.2006.11.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tanaka Y, Nagai Y, Dohdoh M, Oizumi T, Ohki A, Kuroishi T, Sugawara S, Endo Y. <i>In vitro<\/i> cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and\/or etidronate (non-NBP) in tumor cells and periodontal cells. <i>Arch. Oral Biol.<\/i>, <b>58<\/b>, 628\u2013637 (2013).","DOI":"10.1016\/j.archoralbio.2012.11.010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yamaguchi K, Oizumi T, Funayama H, Kawamura H, Sugawara S, Endo Y. Osteonecrosis of the jawbones in 2 osteoporosis patients treated with a nitrogen-containing bisphosphonate: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale. <i>J. Oral Maxillofac. Surg.<\/i>, <b>68<\/b>, 889\u2013897 (2010).","DOI":"10.1016\/j.joms.2009.04.048"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Oizumi T, Funayama H, Yamaguchi K, Yokoyama M, Takahashi H, Yamamoto M, Kuroishi T, Kumamoto H, Sasaki K, Kawamura H, Sugawara S, Endo Y. Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs. <i>J. Oral Maxillofac. Surg.<\/i>, <b>68<\/b>, 1043\u20131054 (2010).","DOI":"10.1016\/j.joms.2009.08.027"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Cornish J, Bava U, Callon KE, Bai J, Naot D, Reid IR. Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells. <i>Bone<\/i>, <b>49<\/b>, 710\u2013716 (2011).","DOI":"10.1016\/j.bone.2011.07.020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Scheper MA, Badros A, Salama AR, Warburton G, Cullen KJ, Weikel DS, Meiller TF. A novel bioassay model to determine clinically significant bisphosphonate levels. <i>Support. Care Cancer<\/i>, <b>17<\/b>, 1553\u20131557 (2009).","DOI":"10.1007\/s00520-009-0710-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Cr\u00e9pin S, Laroche M-L, Sarry B, Merle L. Osteonecrosis of the jaw induced by clodronate, an alkylbisphosphonate: case report and literature review. <i>Eur. J. Clin. Pharmacol.<\/i>, <b>66<\/b>, 547\u2013554 (2010).","DOI":"10.1007\/s00228-010-0822-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Funayama H, Ohsako M, Monma Y, Mayanagi H, Sugawara S, Endo Y. Inhibition of inflammatory and bone\u2013resorption\u2013inhibitory effects of alendronate by etidronate. <i>Calcif. Tissue Int.<\/i>, <b>76<\/b>, 448\u2013457 (2005).","DOI":"10.1007\/s00223-004-0180-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Okada S, Kiyama T, Sato E, Tanaka Y, Oizumi T, Kuroishi T, Takahashi T, Sasaki K, Sugawara S, Endo Y. Inhibition of phosphate transporters ameliorates the inflammatory and necrotic side effects of the nitrogen-containing bisphosphonate zoledronate in mice. <i>Tohoku J. Exp. Med.<\/i>, <b>231<\/b>, 145\u2013158 (2013).","DOI":"10.1620\/tjem.231.145"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. <i>Nat. Rev. Cancer<\/i>, <b>2<\/b>, 584\u2013593 (2002).","DOI":"10.1038\/nrc867"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Rogers MJ, Crockett JC, Coxon FP, M\u00f6nkk\u00f6nen J. Biochemical and cellular mechanisms of action of bisphosphonates. <i>Bone<\/i>, <b>49<\/b>, 34\u201341 (2011).","DOI":"10.1016\/j.bone.2010.11.008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Endo Y, Nakamura M, Kikuchi T, Shinoda H, Takeda Y, Nitta Y, Kumagai K. Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine-synthesis and increase macrophages, granulocytes, and osteoclasts <i>in vivo.<\/i> <i>Calcif. Tissue Int.<\/i>, <b>52<\/b>, 248\u2013254 (1993).","DOI":"10.1007\/BF00298728"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Oizumi T, Yamaguchi Y, Funayama H, Kuroishi T, Kawamura H, Sugawara S, Endo Y. Necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their inhibition by clodronate (a non-NBP) in mice: potential for utilization of clodronate as a combination drug with an NBP. <i>Basic Clin. Pharmacol. Toxicol.<\/i>, <b>104<\/b>, 384\u2013392 (2009).","DOI":"10.1111\/j.1742-7843.2008.00374.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) M\u00f6nkk\u00f6nen J, Koponen H-M, Ylitalo P. Comparison of the distribution of three bisphosphonates in mice. <i>Pharmacol. Toxicol.<\/i>, <b>66<\/b>, 294\u2013298 (1990).","DOI":"10.1111\/j.1600-0773.1990.tb00750.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kiyama T, Tsuchiya M, Okada S, Oizumi T, Yamaguchi K, Sasaki K, Sugawara S, Endo Y. Phosphonocarboxylates can protect mice against the inflammatory and necrotic side effects of nitrogen-containing bisphosphonates by inhibiting their entry into cells <i>via<\/i> phosphate transporters. <i>Biol. Pharm. Bull.<\/i>, <b>39<\/b>, 712\u2013720 (2016).","DOI":"10.1248\/bpb.b15-00770"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, Kreutzer K, Hohlweg-Majert B, Wolff KD, Hafner S, Mast G, Ehrenfeld M, St\u00fcrzenbaum SR, Kolk A. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaw: first clinical results of a prospective pilot study. <i>J. Oral Maxillofac. Surg.<\/i>, <b>69<\/b>, 84\u201391 (2011).","DOI":"10.1016\/j.joms.2010.07.014"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Vescovi P, Meleti M, Merigo E, Manfredi M, Fornaini C, Guidotti R, Nammour S. Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy. <i>Med. Oral Patol. Oral Cir. Bucal<\/i>, <b>18<\/b>, e680\u2013e685 (2013).","DOI":"10.4317\/medoral.18812"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Gallego L, Junquera L, Pelaz A, Hernando J, Megias J. The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla. <i>Med. Oral Patol. Oral Cir. Bucal<\/i>, <b>17<\/b>, e236\u2013e241 (2012).","DOI":"10.4317\/medoral.17422"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Freiberger JJ, Padilla-Burgos R, McGraw T, Suliman HB, Kraft KH, Stolp BW, Moon RE, Piantadosi CA. What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. <i>J. Oral Maxillofac. Surg.<\/i>, <b>70<\/b>, 1573\u20131583 (2012).","DOI":"10.1016\/j.joms.2012.04.001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kim KM, Park W, Oh SY, Kim H-J, Nam W, Lim S-K, Rhee Y, Cha IH. Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. <i>Osteoporos. Int.<\/i>, <b>25<\/b>, 1625\u20131632 (2014).","DOI":"10.1007\/s00198-014-2622-8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Pelaz A, Junquera L, Gallego L, Garcia-Consuegra L, Junquera S, G\u00f3mez C. Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: a pilot study comparing fibrin rich in growth factors and teriparatide. <i>Med. Oral Patol. Oral Cir. Bucal<\/i>, <b>19<\/b>, e320\u2013e326 (2014).","DOI":"10.4317\/medoral.19458"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y. Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance. <i>J. Bone Miner. Metab.<\/i>, <b>27<\/b>, 234\u2013239 (2009).","DOI":"10.1007\/s00774-009-0035-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kim S, Seiryu M, Okada S, Kuroishi T, Takano-Yamamoto T, Sugawara S, Endo Y. Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone. <i>Eur. J. Pharmacol.<\/i>, <b>699<\/b>, 14\u201322 (2013).","DOI":"10.1016\/j.ejphar.2012.11.031"}],"container-title":["Biological &amp; Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/9\/39_b16-00041\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:45:43Z","timestamp":1498326343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/39\/9\/39_b16-00041\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b16-00041","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}